Cargando…
Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
The tau and amyloid pathobiological processes underlying Alzheimer disease (AD) progresses slowly over periods of decades before clinical manifestation as mild cognitive impairment (MCI), then more rapidly to dementia, and eventually to end-stage organ failure. The failure of clinical trials of cand...
Autores principales: | Holland, Dominic, McEvoy, Linda K., Desikan, Rahul S., Dale, Anders M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474753/ https://www.ncbi.nlm.nih.gov/pubmed/23082203 http://dx.doi.org/10.1371/journal.pone.0047739 |
Ejemplares similares
-
Rates of Decline in Alzheimer Disease Decrease with Age
por: Holland, Dominic, et al.
Publicado: (2012) -
Diagnosis and biomarkers of predementia in Alzheimer's disease
por: Forlenza, Orestes V, et al.
Publicado: (2010) -
Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
por: Kauppi, Karolina, et al.
Publicado: (2018) -
Cerebral perfusion in the predementia stages of Alzheimer’s disease
por: Binnewijzend, Maja A. A., et al.
Publicado: (2015) -
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
por: Desikan, Rahul S, et al.
Publicado: (2013)